However, once opened, the vial should be used within 28 days to maintain safety and efficacy, after which it should be discarded
Why Preclinical Results Cannot Resolve the Salt Question Animal studies may investigate BPC-157 under a particular formulation, but they do not establish that every commercial salt form has the same: Purity Stability Absorption Impurity profile Pharmacokinetics Safety A salt-form claim must therefore be supported by evidence concerning that exact material rather than by BPC-157 literature in general
The product sold by clinics is a synthetic 15-amino-acid peptide manufactured by "solid-phase synthesis", administered under the skin, into the muscle or a joint, or intravenously, often at higher doses for weeks
Stability over time also affects effective concentration
Several risk patterns repeat across the research on these nine compounds: Injection-site reactions such as pain, redness, or swelling, reported regardless of which compound is involved